Drug Updates

FDA Action on Loperamide Misuse; Plus Phase 1 Trials for BAT2506 Biosimilar Begin

November 20, 2019 • By Michele B. Kaufman, PharmD, BCGP

Scottish Medicines Consortium Recommends Risankizumab; Plus Real-World Data on Secukinumab

November 4, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Rituximab for Children with GPA & MPA

October 23, 2019 • By Michele B. Kaufman, PharmD, BCGP

Iguratimod May Hold Promise for Treating Autoimmune Disease

October 22, 2019

urfin / shutterstock.com

How to Improve Opioid Prescribing in an Outpatient Clinic

October 18, 2019 • By Lisa Carnago, FNP, Jenelle Hall, PharmD, & Stephanie Puryear, RMA

The Cost of Free Pharmaceutical Services

October 18, 2019 • By Philip Seo

UnitedHealthcare Delays Policy Changes Affecting Physician-Administered Treatments

October 17, 2019 • By From the College

Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

October 14, 2019 • By Mary Choy, PharmD, BCGP, FASHP

Humira, Rituxan Top List of U.S. Drugs with Biggest Price Increases

October 9, 2019 • By Caroline Humer

Nintedanib Slows Lung Deterioration in General Fibrosing Interstitial Lung Disease

October 2, 2019 • By Reuters Staff

1
2
3
…
97
Next Page »